drug
Small Molecules
Preclinicalupdated 6mo agoby Vincere Biosciences Inc
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 2indications
indications
Parkinson's Disease
all catalysts(0)
nothing on the calendar yet
News(10)
- STAT+: Lawmakers want U.S. biotech to outcompete ChinaLawmakers leading the congressional BIOTech Caucus say Washington needs to act in the sector — and fast:stat · 3h ago
- nChroma halves workforce, BioXcel lets execs goFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 5h ago
- With FDA nod, Regeneron brings an RNAi drug to autoimmune diseaseThe product of a collaboration with Alnylam, Livsayis is now Regeneron’s first marketed RNAi drug and will compete against established medicines from AstraZeneca and Argenx.biopharma_dive · 5h ago
- STAT+: Merck, Isomorphic Labs partner to develop oncology drug candidatesMerck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology.stat · 8h ago
- Isomorphic adds Merck to AI drug discovery roster days after $5B raiseIsomorphic Labs’ big week just got bigger. Days after raising $5 billion, the AI-powered biotech has added Merck & Co. to a list of partners that now includes three of the top four drugmakers by re…fiercebiotech · 11h ago
- FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSKThe FDA had several issues with ivonescimab, according to the letter. Elsewhere, Sellas shares rocketed on results for a leukemia vaccine and Biogen and Lilly struck up new R&D pacts.biopharma_dive · 1d ago
- Scientists uncover ‘very detailed map’ of an enzyme target for rare metabolic diseaseFor some rare genetic diseases, the problem isn't a missing protein but the buildup of toxic molecules that the body can no longer clear away.fiercebiotech · 2d ago
- The promise of molecular gates and what comes nextGate Bioscience is developing a new class of medicines designed to eliminate disease-causing proteins at their source. In this episode of "The Top Line," Gate co-founder and CEO Jordi Mata-Fink, Ph…fiercebiotech · 6d ago
- Charles River pays $470M for 2 Frontage bioanalysis labs in PennsylvaniaCharles River Laboratories has acquired Tigermed’s Frontage laboratory sites for $470 million upfront to advance its bioanalysis footprint.fiercebiotech · 6d ago
- London biotech Oyster harvests $60M for tau-targeting brain drugsOyster says a tweak it's made to traditional protein degrading technology can help break down tau, which has long been a focus of Alzheimer’s drug research.biopharma_dive · 9d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that